Lifeboat Foundation

Artificial Intelligence is outgrowing the current pace of Hardware Improvements and requires a new kind of technology to keep up and enable future AI Applications. Scientists seem to have found that creating artificial brains out of nanowire can mimic the human brain and power the biggest and smartest AI models ever made at relatively low energy consumption.

Today’s deep neural networks already mimic one aspect of the brain: its highly interconnected network of neurons. But artificial neurons behave very differently than biological ones, as they only carry out computations. In the brain, neurons are also able to remember their previous activity, which then influences their future behavior. This in-built memory is a crucial aspect of how the brain processes information, and a major strand in neuromorphic engineering focuses on trying to recreate this functionality. This has resulted in a wide range of designs for so-called “memristors”: electrical components whose response depends on the previous signals they have been exposed to.
–

Continue reading “The Rise of Artificial Brains — Nanowire Brain Powers Artificial Intelligence” »

https://www.youtube.com/watch?v=0jCO-CJILHs&feature=share

TWITTER
https://twitter.com/Transhumanian.

PATREON https://www.patreon.com/transhumania.

Continue reading “Nanomachines, Post-Scarcity, and the Universal Constructor (Replicator)” »

Earlier I posted results. Those posts did not include info here concerning topical E5 human trials to start in a month or so and if the results are good they will start up a U.S. factory. So far, 3 treated rats have a 13% longer lifespan than the max for a lab rat and 3 of them are still alive.

In this video we report on the June 2022 update from Dr. Katcher’s experiment with E5, where he is testing to see how long the rats will stay alive if they are given an E5 injection every 90 days. The experiment appears to be coming to an end with only 3 treated rats still alive. But a new experiment has started as well as a human trial of E5 used topically being planned.

Continue reading “Dr Katcher’s E5 Experiment June 2022 Update | Review” »

Greg SwartzThat’s great, but trees and less emissions are the best bet, IMHO.

Shahab Baradaran DilmaghaniThat’s about amount of CO₂ world produces in 30 seconds!😂🤦‍♂️

Is silicon-based life possible? This and some other (very speculative) ideas posted at Big Think. Direct weblink at.

Continue reading “On The Possibility of Silicon-Based Life” »

One possible future perhaps.

The science-fiction short story “The Last Question”, written by Asimov and read by Nimoy.

Our ability to create nano scale products is getting better fast, and these breakthroughs could transform every industry from manufacturing to healthcare and beyond.

Hear from NVIDIA CEO Jensen Huang, @Siemens CEO Roland Busch, and @BMW AG board member Milan Nedeljković as they discuss the next stage of industrial automation. Learn how groundbreaking technologies like Siemens Xcelerator and @NVIDIA Omniverse enable companies of all sizes to build closed-loop, truly real-time, full-design-fidelity immersive digital twins.

Deep dive into the announcements at https://nvda.ws/3npbpdJ.

Continue reading “The Future of AI-Accelerated Industrial Automation with Siemens and NVIDIA” »

Jun Huang from the Pritzker School of Molecular Engineering at the University of Chicago.

Founded in 1,890, the University of Chicago (UChicago, U of C, or Chicago) is a private research university in Chicago, Illinois. Located on a 217-acre campus in Chicago’s Hyde Park neighborhood, near Lake Michigan, the school holds top-ten positions in various national and international rankings. UChicago is also well known for its professional schools: Pritzker School of Medicine, Booth School of Business, Law School, School of Social Service Administration, Harris School of Public Policy Studies, Divinity School and the Graham School of Continuing Liberal and Professional Studies, and Pritzker School of Molecular Engineering.

Irvine, Calif., June 30, 2022 — University of California, Irvine-led researchers have discovered that a signaling molecule called SCUBE3 potently stimulates hair growth and may offer a therapeutic treatment for androgenetic alopecia, a common form of hair loss in both women and men.

The study, published online today in Developmental Cell, determined the precise mechanism by which the dermal papilla cells – specialized signal-making fibroblasts at the bottom of each hair follicle – promote new growth. Although it’s well known that dermal papilla cells play a pivotal role in controlling hair growth, the genetic basis of the activating molecules involved has been poorly understood.

“At different times during the hair follicle life cycle, the very same dermal papilla cells can send signals that either keep follicles dormant or trigger new hair growth,” said Maksim Plikus, Ph.D., UCI professor of developmental & cell biology and the study’s corresponding author. “We revealed that the SCUBE3 signaling molecule, which dermal papilla cells produce naturally, is the messenger used to ‘tell’ the neighboring hair stem cells to start dividing, which heralds the onset of new hair growth.”